We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Messe Düsseldorf to Promote International “MEDICAlliance” Portfolio at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: MEDICA is the No. 1 international medical trade fair worldwide (Photo courtesy of Messe Düsseldorf)
Image: MEDICA is the No. 1 international medical trade fair worldwide (Photo courtesy of Messe Düsseldorf)

Messe Düsseldorf (Düsseldorf, Germany) is participating in the AACC Clinical Lab Expo 2022 in order to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe.

As the No. 1 international medical trade fair worldwide, MEDICA reflects the status of the medical market. Traditionally, MEDICA has featured over 5,000 exhibitors and attracted around 120,000 visitors annually. The exhibitors showcase innovations along the industry's entire value chain and for the complete workflow of modern healthcare. Congresses, various theme parks, forums and numerous special events will complement the exhibits. On average, 800+ international IVD companies and lab equipment manufacturers have participated each year, displaying the latest global advancements in laboratory medicine, equipment, and molecular diagnostic solutions.

At AACC booth 1934, visitor and exhibitor information will be available for MEDICA 2022, World Forum for Medicine, and COMPAMED 2022, High tech solutions for medical technology (held currently from November 14 – 17, 2022 in Düsseldorf, Germany), MEDICAL FAIR ASIA 2022 and MEDICAL MANUFACTURING ASIA 2022 (taking place concurrently from August 31 – September 2, 2022 in Singapore) as well as Medical Fair Thailand (September 13 – 15, 2023 in Bangkok).
 

Related Links:
Messe Düsseldorf

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.